EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome.

EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome. Am Heart J. 2011 Oct; 162(4):620-626.e1.

View in: PubMed

subject areas

Acute Coronary Syndrome
Adult
Aged
Aged, 80 and over
Cardiovascular Diseases
Diabetes Mellitus, Type 2
Diabetic Angiopathies
Dipeptidyl-Peptidase IV Inhibitors
Female
Humans
Male
Middle Aged
Piperidines
Prospective Studies
Treatment Outcome
Uracil

authors with profiles

George Bakris